20 Apr Leading Biopharmaceutical Companies Into The Future After The COVID-19 Crisis
You are invited to a virtual lunch event on the impact of the pandemic on biotechnology and pharmaceutical leadership, hosted by the Swiss INSEAD Healthcare Club (CHIC).
Leading Biopharmaceutical Companies Into The Future After The COVID-19 Crisis
April 20, 2021
A panel of experienced biopharmaceutical leaders, active globally, will discuss the strategic, organisational and talent aspects for the sector as we look forward to coming out of the pandemic. Arul Ramadurai, MBA’05J, Healthcare Club Vice-President, will moderate the discussion, addressing these key questions:
What are the key strategic, organisational and talent considerations for a biopharmaceutical company in the transition into a future after the COVID-19 crisis?
Which areas should a biopharmaceutical company focus on and prioritize for the second half of 2021?
How should these priorities be operationalized to ensure maximum success?
What measures of success will keep organizations motivated?
Panel Members (in alphabetical order)
When: Tuesday April 20, 2021 13:00-14:00 CET on Zoom
Registration: On XING Events https://en.xing-events.com/chicApr21 (The Zoom link will be emailed automatically by XING Events after registering. Check your spam folder if the XING Events email does not appear immediately in your inbox)
INSEAD Alumni Association Switzerland
Arul Ramadurai, MBA’05J, Swiss Healthcare Club Vice-President (moderator)
Aleksandar Ruzicic, MBA’97J, Swiss Healthcare Club President